Approval · Notice of Compliance 612 · 2002
ADVIL EXTRA STRENGTH CAPLETS: Notice of Compliance 612
Issued May 14, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 612
- Date
- May 14, 2002
- Company
- Whitehall-Robins Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of 400mg caplet as a non-prescription product
- Therapeutic class
- Analgesic, antipyretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVIL EXTRA STRENGTH CAPLETS | 02244577 | Marketed |
Medicinal ingredients
- IBUPROFEN 400 MG per TAB